データなし
コード銘柄名
現在値変化額変化率出来高売買代金始値前日終値高値安値時価総額浮動株時価株式総数浮動株5日変化率10日変化率20日変化率60日変化率120日変化率250日変化率年初来配当利回売買回転率直近PER前年PER振幅業種
お気に入り
データなし
NVNO Completes Application for VenoValve's PMA, Shares Likely to Gain
EnVVeno Medical To Present Data From VenoValve Trial At 51st Annual VEITH Symposium; Data Includes Showing 85% Clinical Meaningful Benefit Responder Rate, 87% Median Ulcer Area Reduction
EnVVeno Medical to Present Definitive One Year Data From the VenoValve U.S. Pivotal Trial Today at the 51st Annual VEITH Symposium
EnVVeno Medical Submits PMA Application To FDA To Sell And Market VenoValve In The US
EnVVeno Medical Submits the VenoValve PMA Application Seeking FDA Approval
10-Q:Q3 2024 四半期報告書
データなし
データなし